CytomX Therapeutics (CTMX) Stock: Buy, Sell, or Hold?
$2.04
-0.09 (-4.23%)
▼
5d:
-4.67%
30d:
-8.52%
90d:
-39.29%
QUANTITATIVE VERDICT
BUY
HIGH Confidence (90%)
Quality Score
60/100
Position
OVERSOLD
30-Day Fair Range
$2.15 – $2.48
Position: OVERSOLD
Forward P/E & Valuation
-4.0x
Next 12M consensus est.
Wall Street Target
$12.25
+500.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.90 / $2.39
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
✅ BUY SIGNAL: CTMX shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Get Alerted When CTMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CTMX is currently trading at $2.04, which is considered oversold relative to its 30-day fair value range of $2.15 to $2.48.
Technical Outlook: Technically, CTMX is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.39. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: CTMX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.25 (+500.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTMX is in a strong downtrend. Immediate support is located at $1.90, while resistance sits at $2.39. Short-term momentum is weak, with the stock down 4.2% recently.
Market Sentiment: CTMX scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $12.25 (+500.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.15 -
$2.48
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$2.15 -
$2.48
Current vs Trading Range
OVERSOLD
Support Level
$1.90
Resistance Level
$2.39
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.2%)
- BULLISH: Trading 500.5% below Wall St target ($12.25)
- BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-3.96
Wall Street Target
$12.25
(+500.5%)
Revenue Growth (YoY)
-71.7%
Earnings Growth (YoY)
60.6%
Share CTMX Analysis
Share this live CTMX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CTMX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is filled with bullish sentiment as traders anticipate a potential price surge for $CTMX following a PR update.
Key Retail Themes:
PR update
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:03 AM ET
Data refreshes hourly during market hours. Next update: 6:03 AM
Data refreshes hourly during market hours. Next update: 6:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 53 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CTMX Research Pages
